He told bdnews24.com: "We have received the licence to produce the vaccine for clinical trials. I will now submit our protocol to the Bangladesh Medical Research Council for clinical trials next week. Initially called 'Bancovid', the company in December changed the name of its vaccine candidate to 'Bangavax'. The experimental COVID-19 vaccine features in the World Health Organization’s list of draft landscape of candidate vaccines. In October, the company said the vaccine proved to be “effective” and “completely safe” after trials on rats.

Source: bd News24 January 06, 2021 10:06 UTC